SCHEMBL7190777

SCHEMBL7190777

Cn1cnc(=O)c(=O)[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21894263 0.65 — —
SCHEMBL31710606 0.60 — —
SCHEMBL6279388 0.59 — —
SCHEMBL31685305 0.57 ADORA2A (0.52) —
SCHEMBL9312042 0.55 DAO (0.35) —
SCHEMBL23948971 0.54 — —
SCHEMBL8404471 0.54 — —
SCHEMBL1357553 0.53 — —
SCHEMBL1042322 0.51 — —
SCHEMBL4110758 0.51 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4868173-A CONTAIN AMINE SALT GROUP ICI PHARMA (FR) 1989-09-19 — — US claimed
EP-0182633-A2 Cephalosporin derivatives ICI PHARMA (FR) 1986-05-28 — — EP claimed
US-6566355-B1 Useful in combination with beta -lactam antibiotics in the control of beta -lactamase forming pathogens HOFFMANN-LA ROCHE INC. 2003-05-20 — — US disclosed
US-5698577-A ANTIBIOTICS HOFFMANN-LA ROCHE INC. (US) 1997-12-16 — — US disclosed
US-5510343-A BETA-LACTAMASE INHIBITOR HOFFMANN-LA ROCHE INC. (US) 1996-04-23 — — US disclosed
US-4680408-A SELENAZOLES, CEPHALOSPORIN DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 1987-07-14 — — US disclosed
US-4593093-A Containing a (oxa)cephem structure HOFFMANN-LA ROCHE INC. (US) 1986-06-03 — — US disclosed
EP-0182633-A2 Cephalosporin derivatives ICI PHARMA (FR) 1986-05-28 — — EP disclosed
US-4458072-A CEPHALOSPORIN AND OXACEPHALOSPORIN BACTERICIDES HOFFMANN-LA ROCHE INC. (US) 1984-07-03 — — US disclosed
Send feedback